Published 2 days ago • loading... • Updated 6 hours ago

Costly GLP-1 drug use for weight loss has soared, study reports

Americans' use of GLP-1 drugs like Ozempic for weight loss dramatically increased between 2018 and 2022.
This surge happened as GLP-1 drugs are costly, often running close to $1,000 or more monthly.
Michelle Dowsey led a study providing the first characterization of GLP-1 use among individuals without diabetes.
In 2022, spending on these drugs reached $5.8 billion, averaging $1,540 per prescription, while patients paid about $35 out-of-pocket.
Researchers aim to guide debates on balancing healthcare spending with accessibility of GLP-1 medications, as only 1 in 250 adults used them in 2022.

Insights by Ground AI

Does this summary seem wrong?

17 Articles

All

Left

Center

Right

E! News

Center

Love Is Blind's Chelsea Blackwell Claps Back at Haters Over Weight Loss From Medication

Love Is Blind alum Chelsea Blackwell spoke out after facing criticism for using an injectable medication to help achieve her 30-pound weight loss.

1 day ago·United States

Read Full Article

Quartz

Center

Here's how much Ozempic and similar drugs have soared in popularity since 2018

The use of GLP-1 meds — made popular by Ozempic (NVO) — among U.S. adults without diabetes more than tripled between 2018 and 2022, with annual spending surging from $1.6 billion to $5.8 billion.Read more...

1 day ago·United States

Read Full Article

UPI

Center

Costly GLP-1 drug use for weight loss has soared, study reports

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent years, a new study says.

2 days ago·Washington, United States

Read Full Article

The Blast

Shaun T Defends Lizzo Against Ozempic Rumors

MEGALizzo has been flaunting her new slimmed-down figure over the last several months online, and her detractors have questioned whether her progress came through hard work or the popular weight-loss drug Ozempic. In a new interview, Lizzo's personal trainer, Shaun-T, who hosts popular workout videos like "Insanity" and "T25," opened up about the discourse regarding his client's body and slammed Lizzo's critics as "annoying" before reminding peo…

6 hours ago

Read Full Article

Drug Discovery and Development

GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022

A new analysis reveals GLP-1 use among U.S. adults without diabetes tripled between 2018 and 2022, driving annual spending by this group alone to $5.8 billion by the end of that period. Published in the Annals of Internal Medicine, the Australian study, conducted by researchers at The University of Melbourne, analyzed nationally representative data from… The post GLP-1 use tripled among non-diabetics, hitting $5.8B in 2022 appeared first on Drug…

12 hours ago

Read Full Article

Managed Healthcare Executive

GLP-1 Side Effects Have a Side Effect on Pharmacy Costs

Researchers say payers should take the added costs of drugs prescribed to deal with GLP-1 side effects into account when considering the financial impact of the popular class of drugs.

12 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year